iData’s European gastrointestinal endoscopic devices MedSuite covers 10 markets including the enteral feeding devices market, and hemostasis devices market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s U.S. gastrointestinal endoscopic devices MedSuite covers 11 markets including the enteral feeding devices market, and hemostasis devices market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s China gastrointestinal endoscopy device MedSuite covers 6 markets including the GI endoscopes, capsule endoscopes, stenting device markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s global gastrointestinal endoscopic device MedSuite covers 7 markets including the stenting and dilation and anti-reflux markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s U.S. specimen retrieval and foreign-body removal market MedCore covers the specimen retrieval device market and the foreign-body removal device market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

Adoption is expected to continue over the forecast period, but unit sales will continue exhibiting negative growth, due to the long lifespan of virtual colonoscopy software. One positive factor that might help counter unit erosion is the relative affordability of colonography against optical colonoscopy. Given the growing costs of colonoscopy screening in the United States,

iData’s global stenting and dilation device market MedCore covers the esophageal stent market, duodenal stent market, and 4 more. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

iData’s hemostasis device market MedCore covers the global market. Medcore’s include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

iData’s global gastrointestinal endoscopes market MedCore covers the colonoscope, duodenoscope market, and 3 more. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

Overall, the global endoscopic retrograde cholangiopancreatography (ERCP) device market was valued at nearly $1.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 6.1% to reach nearly $2.6 billion. The full report suite on the global market for ERCP devices includes sphincterotomes, biliary stone removal balloons, biliary stone

iData’s global eternal feeding device market MedCore covers the enteral feeding pump market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

iData’s biopsy forceps, polypectomy snares, and EUS needle device market MedCore covers the global market. Medcore’s include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

Overall, the global capsule endoscopy market was valued at approximately $405 million in 2021. This is expected to increase over the forecast period at a CAGR of 4.1% to reach nearly $538 million. The full report suite on the global market for capsule endoscopy includes camera capsule endoscopy devices. MARKET REPORT DATA TYPES INCLUDED Unit

iData’s anti-reflux device market MedCore covers the global market. Medcore’s include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

GI endoscopy is one of the most widely performed medical procedures in the United States. The majority of these procedures are screenings related to colon cancer or the removal of abnormalities from the GI tract. It is important to note that there is significant overlap between the procedures considered and a patient can, and often

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.